The purpose of this observational trial is to assess application and convenience of Epiduo® PUMP under daily clinical practice conditions in patients with moderate to severe inflammatory acne.
The objective of this observational trial is to assess application and convenience of Epiduo® PUMP under daily clinical practice conditions in patients with moderate to severe inflammatory acne using this drug in topical monotherapy or in combination with other drugs. In addition, efficacy of Epiduo® and incidence of adverse events will be assessed under marketed conditions. Also, patients' body beliefs will be recorded using the dysmorphic concern questionnaire. The observational study is designed as a multicentre study, covering all parts of Germany. Participating investigators are dermatologists with an adequate patient pool of acne patients. The observation time per patient will up to 3 months.
Study Type
OBSERVATIONAL
Enrollment
1,388
Epiduo® gel containing 0.1% adapalene + 2.5% benzoyl peroxide dispensed from a pump.
Severity of acne
Efficacy is assessed by change in severity of acne according to the Leeds revised grading system
Time frame: at baseline and after up to 3 weeks of treatment
Patient-reported assessment
Patient-reported assessment of application and convenience of Epiduo PUMP
Time frame: at follow-up
Physician's assessment
Overall assessment of Epiduo PUMP
Time frame: at follow-up
Adherence
Patient-reported frequency of the application
Time frame: at follow-up
Dysmorphic concern
Assessment of patient's body beliefs using the dysmorphic concern questionnaire
Time frame: at baseline
Adverse drug reactions
Documentation of adverse drug reactions
Time frame: at follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.